Artcline: Funding, Investors & Team (Oct 2026)
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Artcline has raised $14.6M across 3 funding rounds on record, the most recent a Private Equity of $3.9M announced in Sep 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Artcline Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Artcline Funding Rounds
Artcline raised $4.8M in an undisclosed round announced in Mar 2024.
1.5 years later, a Convertible Note of $5.8M was announced in Sep 2025.
1 years later, a Private Equity of $3.9M was announced in Sep 2026.
Artcline Investors
Artcline Founders and Leadership Team
Contact details for the Artcline team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Artcline Funding Compared to Other Biotechnology Startups
Artcline's latest round of $3.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Artcline in Biotechnology and Rostock
Companies Similar to Artcline
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Artcline Funding FAQs
What does Artcline do?
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
How much funding has Artcline raised?
Artcline has raised $14.6M across 3 rounds on record. The most recent is a Private Equity of $3.9M announced in Sep 2026.
When did Artcline last raise funding?
Artcline's most recent funding round on record is a Private Equity of $3.9M, announced in Sep 2026.
Who has invested in Artcline?
Investors on record for Artcline include Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern.
Who founded Artcline?
FundedIQ lists Jens Altrichter (Founder) at Artcline.
Where is Artcline headquartered?
Artcline is based in Rostock, Mecklenburg-Vorpommern, Germany.
How many employees does Artcline have?
Artcline is in the 11-50 employee band.
When was Artcline founded?
Artcline was founded in 2007.
How does Artcline's funding compare to other Biotechnology startups?
Artcline's latest round of $3.9M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Artcline Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artcline is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.